access to medicine index | 2022 Access to Medicine Index

Keyword	CPC	PCC	Volume	Score	Length of keyword
access to medicine index	0.75	0.8	8081	72	24
access	1.01	0.1	9023	61	6
to	1.67	0.3	2451	90	2
medicine	0.02	0.2	1925	32	8
index	0.8	1	829	63	5

Keyword	CPC	PCC	Volume	Score
access to medicine index	1.49	0.4	1808	37
access to medicine index 2024	0.61	0.8	7260	97
access to medicine index 2022	1.42	0.5	8501	82
access to medicine index 2023	1.78	0.4	2997	10
access to medicine index methodology	1.49	0.3	6164	79
access to medicine index 2021	1.95	0.3	7139	21
access to medicine index gsk	0.19	0.2	9779	7
access to medicine index 2019	0.19	0.3	3488	83
access to medicine index atmi	1.13	0.8	2781	81
access to medicine index pfizer	1.04	0.6	3848	38
access to medicine foundation index	0.61	0.6	781	15

Search Results related to access to medicine index on Search Engine

2022 Access to Medicine Index
accesstomedicinefoundation.org

https://accesstomedicinefoundation.org/resource/2022-access-to-medicine-index

WEBNov 15, 2022 · The 8th Access to Medicine Index provides detailed insights into how 20 of the world's leading pharmaceutical companies perform on ensuring people living in low- and middle-income countries have access to the medicines, vaccines and diagnostics they need. Date. 15 November 2022. Read the full report.

DA: 14 PA: 87 MOZ Rank: 84

Access to Medicine Index - Wikipedia
wikipedia.org

https://en.wikipedia.org/wiki/Access_to_Medicine_Index

WEBThe Access to Medicine Index covers a range of diseases based on their aggregate global disease burden and their relevance to pharmaceutical interventions, in accordance with non-age-weighted WHO Disability Adjusted Life Years (DALY) data. In the 2022 Index, the disease scope included 83 diseases, conditions and pathogens identified as the most ...

DA: 3 PA: 14 MOZ Rank: 52

2021 Access to Medicine Index
accesstomedicinefoundation.org

https://accesstomedicinefoundation.org/resource/2021-access-to-medicine-index

WEBJan 26, 2021 · The 2021 Access to Medicine Index analyses the actions of 20 of the world's leading pharmaceutical companies to make medicines, vaccines and diagnostics more accessible. These 20 companies are assessed against 33 metrics spanning R&D, governance, pricing and supply across 106 low- and middle-income countries and for 82 …

DA: 85 PA: 22 MOZ Rank: 10

Company profiles & report cards | Access to Medicine Foundation
accesstomedicinefoundation.org

https://accesstomedicinefoundation.org/sectors-and-research/index-ranking

WEBHow companies were assessed in the 2022 Index. The 2022 Access to Medicine Index assesses 20 of the world’s largest pharmaceutical companies in relation to their efforts to expand access to medicine for people living in 108 low- and middle-income countries.

DA: 61 PA: 76 MOZ Rank: 68

The Methodology for the 2024 Access to Medicine Index
accesstomedicinefoundation.org

https://accesstomedicinefoundation.org/resource/the-methodology-for-the-2024-access-to-medicine-index

WEBOct 10, 2023 · The Methodology for the 2024 Access to Medicine Index. The Methodology Report sets out the analytical framework and metrics by which 20 of the world’s largest pharmaceutical companies will be assessed and ranked for the 2024 Access to Medicine Index. Date. 10 October 2023. Download the full report.

DA: 24 PA: 13 MOZ Rank: 84

Access To Medicine Foundation | Access to Medicine Foundation
accesstomedicinefoundation.org

https://accesstomedicinefoundation.org/

WEBACCESS TO MEDICINE INDEX 2022 2022 RANKING OUR IMPACT. Featured insights. Discover the latest at the Foundation. News. The 2021 AMR Benchmark pinpointed opportunities for companies. Did they take them? Featured News. New 2024 Index Methodology places greater focus on measuring patient reach. Explore per sector. R&D …

DA: 53 PA: 67 MOZ Rank: 6

Now online: 2021 Access to Medicine Index
accesstomedicinefoundation.org

https://accesstomedicinefoundation.org/news/now-online-2021-access-to-medicine-index

WEBJan 26, 2021 · The Access to Medicine Index is an independent ranking of 20 of the world’s leading pharmaceutical companies on their actions to improve access to medicine in 106 countries. Pfizer is new in the top 5 in 2021, just behind GSK, Novartis and Johnson & Johnson, which hold the top three places.

DA: 31 PA: 66 MOZ Rank: 11

2023 Annual Report showcases Foundation’s widening impact | Access …
accesstomedicinefoundation.org

https://accesstomedicinefoundation.org/news/2023-annual-report-showcases-foundation-s-widening-impact

WEBApr 8, 2024 · The Access to Medicine Foundation's 2023 Annual Report, published today, highlights the expanded scale and scope of our work across a diverse range of essential healthcare sectors. In addition to preparing for the upcoming 2024 Access to Medicine Index, we embarked on pioneering research and initiated changemaking activities with …

DA: 25 PA: 55 MOZ Rank: 65

Look ahead: what will the 2022 Access to Medicine Index uncover?
accesstomedicinefoundation.org

https://accesstomedicinefoundation.org/news/look-ahead-what-will-the-2022-access-to-medicine-index-uncover

WEBThe 2022 Index will rank 20 of the world's largest pharma companies on how they perform on improving access to medicine for people in low- and middle-income countries. It looks at companies' products and actions in relation to 83 diseases, conditions and pathogens. The three special reports cover: pandemic preparedness, efforts to improve ...

DA: 56 PA: 16 MOZ Rank: 41

The new Access to Medicine Index - The Lancet
thelancet.com

https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(08)61396-3/fulltext

WEBSep 13, 2008 · The Access to Medicine Index invokes parallels between efficiency and equity, wider implementation of proven treatments, and innovation to produce cheaper or more user-friendly (eg, combination) therapies.

DA: 43 PA: 19 MOZ Rank: 97